Expertise in
20
conditions

Dr. Richard J. Barohn

Neurology
Mizzou Pharmacy-Hitt Street
1020 Hitt St, 
Columbia,, MO 
Accepting New Patients
Referral may be required
Before you request
Expertise in
20
conditions
Mizzou Pharmacy-Hitt Street
1020 Hitt St, 
Columbia,, MO 

Overview

Richard Barohn is a Neurologist practicing medicine in Columbia,, Missouri.

Dr. Barohn is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Inclusion Body Myositis, Myasthenia Gravis, Myositis, Thymectomy, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 180 peer reviewed articles and participating in 9 clinical trials. Dr. Barohn is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in KS

Hospital Affiliations

University Of Missouri Health Care

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

Mizzou Pharmacy-Hitt Street
1020 Hitt St, Columbia,, MO 65212
Other Locations
Office
3599 Rainbow Blvd, Kansas City, KS 66103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Phase 2B Study of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Phase 2B Study of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: November 29, 2022
Intervention Type: Drug
Study Drug: Memantine
Study Phase: Phase 2
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Phase: Phase 3
Understanding Communication and Cognitive Impairments in Neurodegenerative Disorders
Understanding Communication and Cognitive Impairments in Neurodegenerative Disorders
Enrollment Status: Completed
Publish Date: May 17, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Enrollment Status: Completed
Publish Date: October 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Randomized, Placebo Controlled Trial of Tocilizumab in ALS Subjects
A Phase 2 Randomized, Placebo Controlled Trial of Tocilizumab in ALS Subjects
Enrollment Status: Completed
Publish Date: December 18, 2019
Intervention Type: Drug, Other
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
Enrollment Status: Completed
Publish Date: May 07, 2018
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter Observational Study to Assess the Variability of Molecular Biomarkers and Clinical Measures in Patients With Myotonic Dystrophy Type 1
A Multicenter Observational Study to Assess the Variability of Molecular Biomarkers and Clinical Measures in Patients With Myotonic Dystrophy Type 1
Enrollment Status: Completed
Publish Date: October 26, 2017
View 8 Less Clinical Trials

179 Total Publications

Acquired and Genetic Amyloid Neuropathies.
Acquired and Genetic Amyloid Neuropathies.
Journal: Neurologic clinics
Published: October 29, 2025
Similar Doctors
Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

Curators Of The University Of Missouri

1 Hospital Dr, 
Columbia, MO 
 (0.1 miles away)
573-882-1515
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Camilo Gomez is a Neurologist practicing medicine in Columbia, Missouri. Dr. Gomez is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Subarachnoid Hemorrhage, Stent Placement, and Thrombectomy. Dr. Gomez is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

The Curators Of The University Of Missouri

1020 Hitt St, 
Columbia, MO 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brandi French is a Neurologist practicing medicine in Columbia, Missouri. Dr. French is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Cerebral Arteriovenous Malformation, Stent Placement, and Thrombectomy. Dr. French is board certified in American Board Of Psychiatry & Neurology and American Board Of Psychiatry & Neurology-Vascular Neurology. Dr. French is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

The Curators Of The University Of Missouri

1020 Hitt St, 
Columbia, MO 
 (0.1 miles away)
573-882-7129
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Syed Shah is a Neurologist practicing medicine in Columbia, Missouri. Dr. Shah is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Dopa-Responsive Dystonia, Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency, Familial Paroxysmal Nonkinesigenic Dyskinesia, and Drug Induced Dyskinesia. Dr. Shah is board certified in American Board Of Psychiatry & Neurology. Dr. Shah is currently accepting new patients.

Frequently Asked Questions about Dr. Richard J. Barohn

How do I make an appointment with Dr. Richard J. Barohn?

You can book an appointment with Dr. Richard J. Barohn by calling their office at 573-882-1515. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Richard J. Barohn a top-rated expert for Inclusion Body Myositis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Richard J. Barohn is classified as an Elite expert for Inclusion Body Myositis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Richard J. Barohn specialize in?

While Dr. Richard J. Barohn is a Neurology, they have specific expertise in Inclusion Body Myositis, Myasthenia Gravis, and Myositis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Richard J. Barohn participate in research or clinical trials?

Yes. Dr. Richard J. Barohn has published 179 articles and abstracts on conditions like Inclusion Body Myositis. You can view a list of Dr. Richard J. Barohn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Richard J. Barohn accept my insurance?

Dr. Richard J. Barohn accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 573-882-1515 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Barohn's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 50 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile